8.36
price up icon3.34%   0.27
after-market Dopo l'orario di chiusura: 8.50 0.14 +1.67%
loading

Kalvista Pharmaceuticals Inc Azioni (KALV) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
11.45%
33.15
29.75 29.09 31.73 26.95
Operating Income/Loss
11.45%
-33.15
-29.75 -29.09 -31.73 -26.95
Nonoperating Income/Loss
96.71%
4.123
2.096 3.776 5.423 5.642
Income/Loss From Continuing Operations Before Tax
4.98%
-29.03
-27.65 -25.32 -26.30 -21.30
Income/Loss From Continuing Operations After Tax
4.98%
-29.03
-27.65 -25.32 -26.30 -21.30
Net Income/Loss
4.98%
-29.03
-27.65 -25.32 -26.30 -21.30
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.46%
34.72
34.57 34.41 2.0805 28.28
Diluted Average Shares
0.46%
34.72
34.57 34.41 2.0805 28.28
Basic Earnings Per Share
5.00%
-0.84
-0.80 -0.74 -0.75 -0.75
Diluted Earnings Per Share
5.00%
-0.84
-0.80 -0.74 -0.75 -0.75
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):